Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peterse

Showing results (261-270 of 339) with videos related to

Pageof 34
Sort By:
Oncotarget|September 30, 2015
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicinZuzanna Baranski, Yvonne de Jong, Trayana Ilkova, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2006
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?Sunil R Lakhani, Werner Audretsch, Anne-Marie Cleton-Jensen, et al.
Molecular Cancer Research : MCR|September 2, 2017
NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for ChondrosarcomaElisabeth F P Peterse, Brendy E W M van den Akker, Bertine Niessen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapyAnnemarie C Schmitz, Maurice A A J van den Bosch, Claudette E Loo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-upJ G Schrama, I F Faneyte, J H Schornagel, et al.
Journal of Medicinal Chemistry|September 22, 2020
Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long PeptidesNiels R M Reintjens, Elena Tondini, Ana R de Jong, et al.
Cancer Research|August 1, 1994
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutationsR S Cornelis, M van Vliet, C B Vos, et al.
Science Translational Medicine|November 6, 2024
Nociceptor-to-macrophage communication through CGRP/RAMP1 signaling drives endometriosis-associated pain and lesion growth in miceVictor Fattori, Tiago H Zaninelli, Fernanda S Rasquel-Oliveira, et al.
British Journal of Cancer|May 12, 2021
Correction: Effects of cancer screening restart strategies after COVID-19 disruptionLindy M Kregting, Sylvia Kaljouw, Lucie de Jonge, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancerXiaoling Liu, Henne Holstege, Hanneke van der Gulden, et al.
Pageof 34

Showing results (261-270 of 339) with videos related to

Sort By:
Pageof 34
Oncotarget|September 30, 2015
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicinZuzanna Baranski, Yvonne de Jong, Trayana Ilkova, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2006
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?Sunil R Lakhani, Werner Audretsch, Anne-Marie Cleton-Jensen, et al.
Molecular Cancer Research : MCR|September 2, 2017
NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for ChondrosarcomaElisabeth F P Peterse, Brendy E W M van den Akker, Bertine Niessen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapyAnnemarie C Schmitz, Maurice A A J van den Bosch, Claudette E Loo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-upJ G Schrama, I F Faneyte, J H Schornagel, et al.
Journal of Medicinal Chemistry|September 22, 2020
Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long PeptidesNiels R M Reintjens, Elena Tondini, Ana R de Jong, et al.
Cancer Research|August 1, 1994
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutationsR S Cornelis, M van Vliet, C B Vos, et al.
Science Translational Medicine|November 6, 2024
Nociceptor-to-macrophage communication through CGRP/RAMP1 signaling drives endometriosis-associated pain and lesion growth in miceVictor Fattori, Tiago H Zaninelli, Fernanda S Rasquel-Oliveira, et al.
British Journal of Cancer|May 12, 2021
Correction: Effects of cancer screening restart strategies after COVID-19 disruptionLindy M Kregting, Sylvia Kaljouw, Lucie de Jonge, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancerXiaoling Liu, Henne Holstege, Hanneke van der Gulden, et al.
Pageof 34